Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe shines at AACC 2018

    The 70th AACC Annual Scientific Meeting & Clinical Lab Expo., attracting more than 22,000 visitors and 500 exhibitors to share the most recent technology available in the medical laboratory market, was held at McCormick Place, Chicago, USA from Jul. 29 to Aug. 2.
    Issue date:2018-08-01

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 23years

137Countries

9000Units

More